We are live on
!
Find out more
KC
Karras Company Portfolio holdings
AUM
$110M
This Fund
S&P 500
This Quarter
Est. Return
+18.04%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$110M
AUM Growth
+$11.7M
(+12%)
Cap. Flow
-$2.11M
Cap. Flow
% of AUM
-1.91%
Top 10 Holdings %
Top 10 Hldgs %
62.11%
Holding
64
New
3
Increased
15
Reduced
40
Closed
3
Avg Time Held
1.8
quarters
Top 10 Avg Time Held
1.8
quarters
Top 20 Avg Time Held
1.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19M |
| 2 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$540K |
| 3 |
Amplify International Enhanced Dividend Income ETF
IDVO
|
+$372K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$209K |
| 5 |
Copa Holdings
CPA
|
+$204K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.13M |
| 2 |
AKRE
Akre Focus ETF
AKRE
|
+$1.08M |
| 3 |
Corning
GLW
|
+$604K |
| 4 |
Salesforce
CRM
|
+$396K |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$346K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.99% |
| 2 | Technology | 29.18% |
| 3 | Communication Services | 8.37% |
| 4 | Financials | 7.18% |
| 5 | Healthcare | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Lockheed Martin
LMT
$118B
| $1.18M | 1.07% |
2,307
-52
| -2% | -$28.1K |
2025 Q4
2 quarters
|
|
27
Vistra
VST
$54.2B
| $1.06M | 0.96% |
6,688
-115
| -2% | -$17.8K |
2025 Q4
2 quarters
|
|
28
Johnson & Johnson
JNJ
$630B
| $919K | 0.83% |
3,618
-235
| -6% | -$54.8K |
2025 Q4
2 quarters
|
|
29
Oracle
ORCL
$429B
| $885K | 0.8% |
6,036
-93
| -2% | -$16.9K |
2025 Q4
2 quarters
|
|
30
Dell
DELL
$373B
| $746K | 0.68% |
1,729
-426
| -20% | -$123K |
2025 Q4
2 quarters
|
|
31
ExxonMobil
XOM
$695B
| $721K | 0.65% |
5,273
-93
| -2% | -$13.9K |
2025 Q4
2 quarters
|
|
32
Rio Tinto
RIO
$154B
| $692K | 0.63% |
7,291
-256
| -3% | -$26K |
2025 Q4
2 quarters
|
|
33
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.91B
| $685K | 0.62% |
15,000
-505
| -3% | -$23.1K |
2025 Q4
2 quarters
|
|
34
iShares Core MSCI Total International Stock ETF
IXUS
$58.7B
| $685K | 0.62% |
7,176
+514
| +8% | +$48.3K |
2025 Q4
2 quarters
|
|
35
Deere & Co
DE
$167B
| $680K | 0.62% |
1,072
-10
| -0.9% | -$5.79K |
2025 Q4
2 quarters
|
|
36
ServiceNow
NOW
$146B
| $633K | 0.57% |
6,380
-2,187
| -26% | -$217K |
2026 Q1
1 quarter
|
|
37
Berkshire Hathaway Class B
BRK.B
$1.1T
| $615K | 0.56% |
1,230
-84
| -6% | -$40.4K |
2025 Q4
2 quarters
|
|
38
Home Depot
HD
$290B
| $614K | 0.56% |
1,740
-429
| -20% | -$140K |
2025 Q4
2 quarters
|
|
39
Union Pacific
UNP
$165B
| $591K | 0.54% |
2,171
-32
| -1% | -$8.4K |
2025 Q4
2 quarters
|
|
40
TD Synnex
SNX
$21.8B
| $588K | 0.53% |
2,199
-364
| -14% | -$87.7K |
2025 Q4
2 quarters
|
|
41
Merit Medical Systems
MMSI
$5.21B
| $551K | 0.5% |
7,950
-3,575
| -31% | -$236K |
2025 Q4
2 quarters
|
|
42
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.1B
| $427K | 0.39% |
7,598
-100
| -1% | -$5.41K |
2025 Q4
2 quarters
|
|
43
Cigna
CI
$74.6B
| $412K | 0.37% |
1,496
+188
| +14% | +$53.1K |
2026 Q1
1 quarter
|
|
44
Vanguard S&P 500 ETF
VOO
$1.06T
| $400K | 0.36% |
583
+169
| +41% | +$113K |
2025 Q4
2 quarters
|
|
45
UnitedHealth
UNH
$340B
| $382K | 0.35% |
918
-33
| -3% | -$12.2K |
2025 Q4
2 quarters
|
|
46
Accenture
ACN
$128B
| $354K | 0.32% |
2,846
+813
| +40% | +$141K |
2025 Q4
2 quarters
|
|
47
Linde
LIN
$223B
| $343K | 0.31% |
662
+33
| +5% | +$16.7K |
2025 Q4
2 quarters
|
|
48
Amgen
AMGN
$224B
| $338K | 0.31% |
933
-57
| -6% | -$19.5K |
2025 Q4
2 quarters
|
|
49
Walmart Inc
WMT
$883B
| $332K | 0.3% |
2,933
-328
| -10% | -$40.7K |
2025 Q4
2 quarters
|
|
50
SoFi Technologies
SOFI
$20.4B
| $298K | 0.27% |
16,600
-436
| -3% | -$7.39K |
2025 Q4
2 quarters
|
|
Similar funds
FI
ZS
CIM
BFA
FAOAI
IWA
SM
WPWM
Karras Company's Q2 2026 Portfolio in Review
As of Q2 2026, Karras Company held 64 positions worth $110M, up 12% from $98.6M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Karras Company's Q2 2026 filing shows 3 new, 15 increased, 40 reduced and 3 closed positions. Its largest new stake was AstraZeneca: 11,623 shares worth $2.2M. The largest sale was Microsoft, an estimated $1.13M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 36% a quarter earlier, followed by Technology and Communication Services.
- Karras Company's largest Q2 2026 buy was AstraZeneca: 11,623 shares worth $2.2M.
- Karras Company added most to iShares Core MSCI International Developed Markets ETF in Q2 2026, an estimated $540K increase.
- Karras Company's biggest Q2 2026 reduction was Akre Focus ETF, cutting an estimated $1.08M.
- Karras Company fully exited Microsoft in Q2 2026, selling an estimated $1.13M.
- Karras Company's ten largest holdings make up 62% of its $110M portfolio in Q2 2026.
- Karras Company opened 3 new positions and closed 3 in Q2 2026.
- Karras Company's portfolio value rose 12% quarter-over-quarter to $110M.
Based on Karras Company's 13F filing for Q2 2026, filed 23 Jul 2026.